Private Advisor Group’s Larimar Therapeutics LRMR Stock Holding History

Private Advisor Group’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-121	Closed	-$2K	–	2647
2020 Q2	$2K	Buy	+121	New	+$1.41K	﹤0.01%	3578
2019 Q1	–	Sell	-961	Closed	-$57K	–	1576
2018 Q4	$57K	Sell	961 -500	-34%	-$49.4K	﹤0.01%	1317
2018 Q3	$205K	Buy	1,461 +128	+10%	+$15.5K	﹤0.01%	1437
2018 Q2	$153K	Buy	+1,333	New	+$113K	﹤0.01%	1230
2018 Q1	–	Sell	-1,333	Closed	-$87K	–	1283
2017 Q4	$87K	Buy	1,333 +299	+29%	+$13.5K	﹤0.01%	1146
2017 Q3	$42K	Buy	1,034 +167	+19%	+$6.95K	﹤0.01%	1443
2017 Q2	$35K	Hold	867	–	–	﹤0.01%	1361
2017 Q1	$52K	Buy	+867	New	+$43K	﹤0.01%	1387

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return